BIO-key Surpasses $2M of Military/Defense Sales over Last 12 months with Follow-on Order From Foreign Defense Ministry; Geopolitical Tensions Raise Stakes for Securing Intelligence Against Cyber Threats
MWN-AI** Summary
BIO-key International, Inc. (NASDAQ: BKYI), a leader in biometric-centric Identity and Access Management (IAM) solutions, has reported significant growth in military and defense sales, surpassing $2 million over the past year. A notable milestone includes a $280,000 follow-on order from the cyber-defense unit of a foreign ministry, raising total sales from this client to $1.14 million within the same period. This marked increase reflects heightened demand for robust cybersecurity measures amid escalating geopolitical tensions, particularly in regions like the Middle East.
BIO-key's biometric authentication technology is designed to provide strong, user-friendly multi-factor authentication that mitigates risks associated with traditional security measures, such as credential sharing and phishing attacks. The platform enables phoneless and tokenless authentication, crucial for operations in Sensitive Compartmented Information Facilities (SCIFs) where such devices may be prohibited. Currently, BIO-key supports over 50,000 licensed users for this ministry, with plans for further expansion.
The company's focus includes serving military and defense agencies globally, with an emphasis on securing national intelligence and sensitive information. Jim Sullivan, SVP of Strategy, highlighted the trust established with this long-term client, underlining BIO-key's commitment to delivering high standards of security, usability, and compliance with stringent military requirements.
Michael DePasquale, Chairman and CEO, reinforced the company's strategic direction with the launch of the Defense & Intelligence Cybersecurity Initiative in mid-2025. This initiative aims to enhance security for new defense agency clients amid increasing cyber threats. Given the current global climate and anticipated rise in cyberattacks, BIO-key expects continued demand for their advanced biometric solutions in defense and intelligence sectors.
MWN-AI** Analysis
BIO-key International, Inc. (NASDAQ: BKYI) has recently demonstrated significant growth in military and defense sales, exceeding $2 million over the past 12 months. This milestone was underpinned by a new $280,000 order from a foreign defense ministry, further solidifying BIO-key’s position within the burgeoning cybersecurity sector amidst escalating geopolitical tensions.
As global hostilities rise, particularly in volatile regions like the Middle East, the demand for robust cybersecurity measures in military and intelligence operations is amplified. BIO-key’s biometric authentication platform offers a unique advantage with its "who-you-are" approach, which mitigates risks associated with credential sharing and cyber threats—essential in environments where traditional authentication methods, such as tokens and phones, may be impractical. This capability can be highly attractive to government and military customers seeking to protect sensitive information and secure systems against increasing cyberattacks.
Investors should view BIO-key's continued expansion into military and defense sectors positively, especially with the increasing emphasis on cybersecurity standards in sensitive areas. The company’s commitment to quality is evident through its certifications, including NIST and FIPS 201, which bolster their credibility in the market.
However, investors should consider the potential volatility associated with defense spending and government contracts, which may be impacted by broader budgetary constraints and shifting political climates. While the recent growth is promising, it is imperative to monitor future contract acquisitions and the success of BIO-key's Defense & Intelligence Cybersecurity Initiative, which has initiated new customer engagement.
In summary, BIO-key presents an intriguing investment opportunity in a vital industry as geopolitical tensions mount. Its innovative approach to biometric authentication is timely and necessary, making it a contender for investors focused on the intersection of technology and defense. Cautious optimism appears warranted as the company seeks to expand its market footprint amidst ongoing global challenges.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
HOLMDEL, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), a provider of biometric-centric Identity and Access Management (IAM) solutions, today announced that the cyber-defense unit of a foreign defense ministry placed a $280,000 in new order to expand its deployment of BIO-key’s biometric user authentication to additional personnel. The order brings total business booked from this customer in the past 12 months to $1.14M with additional orders expected. Across the broader military and defense sector BIO-key has secured over $2M in total orders over the last 12 months, representing a substantial increase over the year-ago period.
Rising geopolitical tensions, particularly in the Middle East, have increased demand for hardened authentication across foreign defense and intelligence agencies. BIO-key’s biometric authentication platform delivers strong, easy-to-use multi-factor authentication and identification. Unlike possession-based tokens and phone-based factors, BIO-key’s “who-you-are” approach effectively eliminates the risk of credential sharing and phishing and can authenticate users without requiring assigning them a separate device.
BIO-key supports phoneless, tokenless authentication for Sensitive Compartmented Information Facilities (SCIFs) and Foreign Material Exclusion (FME) areas—environments common in defense and intelligence operations—where phones, tokens, and other removable devices can be impractical or prohibited. At this customer, BIO-key now supports authentication for more than 50,000 licensed users, providing continuous availability and detailed auditability as the ministry expands to additional personnel. BIO-key’s platform is designed to scale to millions of users across large enterprises and government agencies. Because biometric credentials are inherent to the individual, secure access to highly sensitive systems cannot be easily shared, delegated, phished, or forgotten—critical factors amid increasing cyberthreats and phishing attacks.
“This ministry is among the most discriminating buyers of cybersecurity technologies in the world and a customer since 2017,” said Jim Sullivan, SVP of Strategy and Chief Legal Officer, BIO-key. “We are proud to have earned their trust by delivering the highest levels of security, usability, and ease of deployment for nearly a decade. Our certifications — including NIST, FBI FAP and FIPS 201 — provide our defense customers a reliable, standards-compliant security experience that meets the rigorous requirements of military and intelligence environments.”
“BIO-key continues to expand its presence with military and defense ministries that require reliable biometric solutions to protect critical national intelligence and other highly sensitive, eyes-only information,” said Michael DePasquale, Chairman and CEO. “In mid-2025, we launched BIO-key’s Defense & Intelligence Cybersecurity Initiative, a targeted sales program focused on delivering hardened biometric authentication and IAM solutions to military and intelligence customers. The initiative has already helped harden the security posture of several new defense agency customers. Today, we serve military, defense, and other government agencies in multiple countries, including in Europe and the Middle East. Given rising global hostilities and the likely increase in cyberattacks, we anticipate continued interest and growth in our Defense & Intelligence Cybersecurity Initiative.”
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
Engage with BIO-key:
| LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international | |
| X – Corporate: | @BIOkeyIntl | |
| X – Investors: | @BIO_keyIR | |
| StockTwits: | BIO_keyIR | |
Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com or 212-924-9800
FAQ**
How does BIO-key International Inc. BKYI plan to leverage its recent $1.14M in orders to expand its market presence in the defense sector amidst rising cyber threats?
What specific features of BIO-key International Inc. BKYI’s biometric authentication platform are most appealing to its military clients, and how do they compare to competitors?
Given the increasing demand for cybersecurity solutions, what are BIO-key International Inc. BKYI’s projections for growth in the Defense & Intelligence Cybersecurity Initiative over the next few years?
How does BIO-key International Inc. BKYI ensure its biometric solutions remain compliant with rigorous military standards and adapt to evolving cyber threats in the defense sector?
**MWN-AI FAQ is based on asking OpenAI questions about BIO-key International Inc. (NASDAQ: BKYI).
NASDAQ: BKYI
BKYI Trading
0.65% G/L:
$0.6312 Last:
104,281 Volume:
$0.6499 Open:
